NEW YORK – A Johns Hopkins University research team has collected new evidence that future noninvasive tests for prostate cancer might rely on an analysis of RNA and metabolite patterns in urine, either in lieu of or in addition to the DNA biomarkers that have become so exciting in the field of liquid biopsy.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.